| scholarly article | Q13442814 |
| P50 | author | William Bamlet | Q48925451 |
| Thomas C. Smyrk | Q64371564 | ||
| P2093 | author name string | Alan P Fields | |
| Nicole R Murray | |||
| Michele L Scotti | |||
| P2860 | cites work | Protein kinase C iota mediates lipid-induced apoptosis of human coronary artery endothelial cells | Q24310371 |
| Oncogenic K-ras promotes early carcinogenesis in the mouse proximal colon | Q34749595 | ||
| Identification of a small molecule with synthetic lethality for K-ras and protein kinase C iota | Q34828123 | ||
| In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice | Q35575178 | ||
| Molecular-targeted agents in pancreatic cancer | Q35641998 | ||
| Protein kinase Ciota is required for Ras transformation and colon carcinogenesis in vivo | Q36322263 | ||
| Protein kinase C betaII and TGFbetaRII in omega-3 fatty acid-mediated inhibition of colon carcinogenesis | Q36325748 | ||
| Atypical protein kinase C iota expression and aurothiomalate sensitivity in human lung cancer cells | Q37143104 | ||
| Protein kinase Cbeta is an effective target for chemoprevention of colon cancer | Q37349308 | ||
| Matrix metalloproteinase-10 is a critical effector of protein kinase Ciota-Par6alpha-mediated lung cancer | Q37361313 | ||
| Atypical protein kinase C{iota} is required for bronchioalveolar stem cell expansion and lung tumorigenesis | Q37373237 | ||
Long-term survival and prognostic indicators in small (| Q37464630 | | ||
| Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis | Q38337872 | ||
| Genomic mechanisms of p210BCR-ABL signaling: induction of heat shock protein 70 through the GATA response element confers resistance to paclitaxel-induced apoptosis | Q38340918 | ||
| Atypical protein kinases Clambda and -zeta associate with the GTP-binding protein Cdc42 and mediate stress fiber loss | Q39452193 | ||
| Role of protein kinase C-iota in transformed non-malignant RWPE-1 cells and androgen-independent prostate carcinoma DU-145 cells | Q39879775 | ||
| Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. | Q40144497 | ||
| Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma. | Q40285051 | ||
| Molecular target-based therapy of pancreatic cancer | Q40314224 | ||
| A novel small-molecule inhibitor of protein kinase Ciota blocks transformed growth of non-small-cell lung cancer cells | Q40321941 | ||
| p8 is a new target of gemcitabine in pancreatic cancer cells | Q40333276 | ||
| Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer | Q40365768 | ||
| Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity | Q40402576 | ||
| Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity | Q40515725 | ||
| Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines | Q40552196 | ||
| Protein kinase C (PKC) betaII induces cell invasion through a Ras/Mek-, PKC iota/Rac 1-dependent signaling pathway | Q40575136 | ||
| Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1 | Q40647436 | ||
| Telomerase activity of cultured human pancreatic carcinoma cell lines correlates with their potential for migration and invasion | Q40828591 | ||
| Evidence that atypical protein kinase C-lambda and atypical protein kinase C-zeta participate in Ras-mediated reorganization of the F-actin cytoskeleton. | Q42056986 | ||
| Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer | Q42631961 | ||
| K-ras mutations in pancreatic ductal proliferative lesions | Q42753837 | ||
| Reversion of Ras- and phosphatidylcholine-hydrolyzing phospholipase C-mediated transformation of NIH 3T3 cells by a dominant interfering mutant of protein kinase C lambda is accompanied by the loss of constitutive nuclear mitogen-activated protein k | Q42801458 | ||
| The use of a tropism-modified measles virus in folate receptor-targeted virotherapy of ovarian cancer | Q45410754 | ||
| Characterization of the CXCR4 signaling in pancreatic cancer cells | Q46823256 | ||
| Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma. | Q53594703 | ||
| Aurothiomalate Inhibits Transformed Growth by Targeting the PB1 Domain of Protein Kinase Cι | Q57271956 | ||
| Suppression of Ki-ras p21 levels leading to growth inhibition of pancreatic cancer cell lines with Ki-ras mutation but not those without Ki-ras mutation | Q73864505 | ||
| Protein kinase C isoforms involved in the transcriptional activation of cyclin D1 by transforming Ha-Ras | Q74499731 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic cancer | Q212961 |
| P304 | page(s) | 2064-2074 | |
| P577 | publication date | 2010-02-23 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Protein kinase Ciota is required for pancreatic cancer cell transformed growth and tumorigenesis | |
| P478 | volume | 70 |
| Q58173395 | A Cancer-Associated Mutation in Atypical Protein Kinase C Occurs in a Substrate-Specific Recruitment Motif |
| Q37458491 | A phase I, dose-finding study of sorafenib in combination with gemcitabine and radiation therapy in patients with unresectable pancreatic adenocarcinoma: a Grupo Español Multidisciplinario en Cáncer Digestivo (GEMCAD) study |
| Q38882024 | A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion |
| Q27684030 | Adenosine-binding motif mimicry and cellular effects of a thieno[2,3-d]pyrimidine-based chemical inhibitor of atypical protein kinase C isoenzymes |
| Q38185497 | Apico-basal polarity complex and cancer |
| Q38162656 | Atypical protein kinase Cι as a human oncogene and therapeutic target |
| Q30496644 | Coordination of glioblastoma cell motility by PKCι |
| Q39020777 | Ellagic acid induces novel and atypical PKC isoforms and promotes caspase-3 dependent apoptosis by blocking energy metabolism |
| Q38276290 | Epidermal polarity genes in health and disease |
| Q101574540 | Equivocal, explicit and emergent actions of PKC isoforms in cancer |
| Q34745252 | Molecular characteristics of pancreatic ductal adenocarcinoma |
| Q39335137 | Overexpression of CIAPIN1 inhibited pancreatic cancer cell proliferation and was associated with good prognosis in pancreatic cancer |
| Q51600862 | PKC iota promotes cellular proliferation by accelerated G1/S transition via interaction with CDK7 in esophageal squamous cell carcinoma. |
| Q24297584 | PKC-ι promotes glioblastoma cell survival by phosphorylating and inhibiting BAD through a phosphatidylinositol 3-kinase pathway |
| Q58697716 | PKCι and YAP1 are crucial in promoting pancreatic tumorigenesis |
| Q37466903 | PKCι maintains a tumor-initiating cell phenotype that is required for ovarian tumorigenesis. |
| Q34038395 | PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis |
| Q47154650 | PRKCI promotes immune suppression in ovarian cancer |
| Q37608855 | Phase I dose escalation study of the PKCι inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer. |
| Q64055869 | Preclinical pharmacodynamic evaluation of a new Src/FOSL1 inhibitor, LY-1816, in pancreatic ductal adenocarcinoma |
| Q59072618 | Protein Kinase C (PKC) Isozymes and Cancer |
| Q38171231 | Protein kinase C and cancer: what we know and what we do not. |
| Q35987724 | Protein kinase C iota as a therapeutic target in alveolar rhabdomyosarcoma. |
| Q35050703 | Protein kinase C iota in the intestinal epithelium protects against dextran sodium sulfate-induced colitis |
| Q28480889 | Protein kinase C iota regulates pancreatic acinar-to-ductal metaplasia |
| Q47925821 | Protein kinase C isoforms in the normal pancreas and in pancreatic disease |
| Q34981351 | Protein kinase C zeta regulates human pancreatic cancer cell transformed growth and invasion through a STAT3-dependent mechanism |
| Q37491175 | Protein kinase Cα suppresses Kras-mediated lung tumor formation through activation of a p38 MAPK-TGFβ signaling axis. |
| Q34787801 | Protein kinase Cι expression and oncogenic signaling mechanisms in cancer. |
| Q53722723 | Protein kinase Cι is a new prognostic factor in gastric cancer. |
| Q39653312 | Protein kinase D1 promotes anchorage‐independent growth, invasion, and angiogenesis by human pancreatic cancer cells |
| Q39453904 | Regulation of Cdk7 activity through a phosphatidylinositol (3)-kinase/PKC-ι-mediated signaling cascade in glioblastoma |
| Q53073068 | Regulation of chondrocyte proliferation through GIT1-Rac1-mediated ERK1/2 pathway by PDGF. |
| Q37537542 | Regulation of polarized morphogenesis by protein kinase C iota in oncogenic epithelial spheroids. |
| Q39436597 | Repression of cancer cell senescence by PKCι. |
| Q35747051 | Role of ellagic acid in regulation of apoptosis by modulating novel and atypical PKC in lymphoma bearing mice |
| Q34279846 | Role of protein kinase D signaling in pancreatic cancer |
| Q92067558 | Targeting Rho GTPase Signaling Networks in Cancer |
| Q48678789 | Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism |
| Q37673912 | Targeting oncogenic protein kinase Cι for treatment of mutant KRAS LADC. |
| Q28081364 | Targeting protein kinase C subtypes in pancreatic cancer |
| Q38242808 | Targeting tight junctions during epithelial to mesenchymal transition in human pancreatic cancer. |
| Q36510237 | The chromosome 3q26 OncCassette: A multigenic driver of human cancer |
| Q38981224 | The interruption of PKC-ι signaling and TRAIL combination therapy against glioblastoma cells |
| Q64947801 | The modulation of actin dynamics via atypical Protein Kinase-C activated Cofilin regulates metastasis of colorectal cancer cells. |
| Q64121611 | aPKCι promotes gallbladder cancer tumorigenesis and gemcitabine resistance by competing with Nrf2 for binding to Keap1 |
| Q47805359 | miR-217-5p induces apoptosis by directly targeting PRKCI, BAG3, ITGAV and MAPK1 in colorectal cancer cells |
Search more.